AdBio Partners, a Paris-based venture capital fund backed by the French and European governments, is establishing a new office in Montréal, Canada. This expansion signals increased European investment into Canada's life sciences sector, which has faced funding challenges recently. The firm is also launching a new €120 million fund, allocating a portion to Québec-based companies, potentially bridging Canadian and European biotech innovation.
Read the full article at BetaKit
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.



